Anna-Line Calatayud

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Jessica Zucman-Rossi, Michael R Stratton, Sandrine Imbeaud, 2015, Nature Genetics.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2017, Clinical Cancer Research.

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2019, Gastroenterology.

RSK2 inactivation cooperates with AXIN1 inactivation or ß-catenin activation to promote hepatocarcinogenesis.

J. Zucman‐Rossi, J. Calderaro, S. Rebouissou, 2023, Journal of hepatology.